Literature DB >> 12089316

Quality control strains used in susceptibility testing of Campylobacter spp.

Antti Hakanen, Pentti Huovinen, Pirkko Kotilainen, Anja Siitonen, Hannele Jousimies-Somer.   

Abstract

Mesh:

Year:  2002        PMID: 12089316      PMCID: PMC120564          DOI: 10.1128/JCM.40.7.2705-2706.2002

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  4 in total

1.  Quinolone-resistant Campylobacter jejuni infections in Minnesota, 1992-1998. Investigation Team.

Authors:  K E Smith; J M Besser; C W Hedberg; F T Leano; J B Bender; J H Wicklund; B P Johnson; K A Moore; M T Osterholm
Journal:  N Engl J Med       Date:  1999-05-20       Impact factor: 91.245

2.  In vitro activity of the new ketolide telithromycin compared with those of macrolides against Streptococcus pyogenes: influences of resistance mechanisms and methodological factors.

Authors:  P Bemer-Melchior; M E Juvin; S Tassin; A Bryskier; G C Schito; H B Drugeon
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

3.  Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolates.

Authors:  J Engberg; F M Aarestrup; D E Taylor; P Gerner-Smidt; I Nachamkin
Journal:  Emerg Infect Dis       Date:  2001 Jan-Feb       Impact factor: 6.883

4.  Evolution of susceptibilities of Campylobacter spp. to quinolones and macrolides.

Authors:  R Sánchez; V Fernández-Baca; M D Díaz; P Muñoz; M Rodríguez-Créixems; E Bouza
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191

  4 in total
  8 in total

1.  Genetic diversity and antibiotic resistance patterns in a campylobacter population isolated from poultry farms in Switzerland.

Authors:  M Wittwer; J Keller; T M Wassenaar; R Stephan; D Howald; G Regula; B Bissig-Choisat
Journal:  Appl Environ Microbiol       Date:  2005-06       Impact factor: 4.792

2.  Fluoroquinolone resistance in Campylobacter jejuni isolates in travelers returning to Finland: association of ciprofloxacin resistance to travel destination.

Authors:  Antti Hakanen; Hannele Jousimies-Somer; Anja Siitonen; Pentti Huovinen; Pirkko Kotilainen
Journal:  Emerg Infect Dis       Date:  2003-02       Impact factor: 6.883

3.  Inhibition of Bacteria Associated with Wound Infection by Biocompatible Green Synthesized Gold Nanoparticles from South African Plant Extracts.

Authors: 
Journal:  Nanomaterials (Basel)       Date:  2017-11-26       Impact factor: 5.076

4.  Effects of Microplate Type and Broth Additives on Microdilution MIC Susceptibility Assays.

Authors:  Angela Kavanagh; Soumya Ramu; Yujing Gong; Matthew A Cooper; Mark A T Blaskovich
Journal:  Antimicrob Agents Chemother       Date:  2018-12-21       Impact factor: 5.191

5.  Nitroxide Functionalized Antibiotics Are Promising Eradication Agents against Staphylococcus aureus Biofilms.

Authors:  Anthony D Verderosa; Rabeb Dhouib; Kathryn E Fairfull-Smith; Makrina Totsika
Journal:  Antimicrob Agents Chemother       Date:  2019-12-20       Impact factor: 5.191

6.  Bioactive glass S53P4 eradicates Staphylococcus aureus in biofilm/planktonic states in vitro.

Authors:  Torstein Grønseth; Lene K Vestby; Live L Nesse; Magnus von Unge; Juha T Silvola
Journal:  Ups J Med Sci       Date:  2020-06-18       Impact factor: 2.384

7.  Assessing the antibiotic susceptibility of freshwater Cyanobacteria spp.

Authors:  Elsa Dias; Micaela Oliveira; Daniela Jones-Dias; Vitor Vasconcelos; Eugénia Ferreira; Vera Manageiro; Manuela Caniça
Journal:  Front Microbiol       Date:  2015-08-11       Impact factor: 5.640

8.  Quinoline Antimalarials Increase the Antibacterial Activity of Ampicillin.

Authors:  Olajumoke A Olateju; Chinedum P Babalola; Olujide O Olubiyi; Olayinka A Kotila; David A Kwasi; Anderson O Oaikhena; Iruka N Okeke
Journal:  Front Microbiol       Date:  2021-06-02       Impact factor: 5.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.